74 related articles for article (PubMed ID: 32951317)
1. Epigenetic Mechanisms of LncRNAs Binding to Protein in Carcinogenesis.
Shin TJ; Lee KH; Cho JY
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050646
[TBL] [Abstract][Full Text] [Related]
2. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
[TBL] [Abstract][Full Text] [Related]
3. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
He Z; Chen J; Chen X; Wang H; Tang L; Han C
J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death.
Gupta S; Silveira DA; Mombach JCM; Hashimoto RF
Noncoding RNA Res; 2023 Dec; 8(4):605-614. PubMed ID: 37767112
[TBL] [Abstract][Full Text] [Related]
5. E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia.
Liu Y; Chen P; Chen G; Chen X
Ann Hematol; 2023 Dec; 102(12):3345-3355. PubMed ID: 37665348
[TBL] [Abstract][Full Text] [Related]
6. The RNA interactome in the Hallmarks of Cancer.
Gabryelska MM; Conn SJ
Wiley Interdiscip Rev RNA; 2023; 14(5):e1786. PubMed ID: 37042179
[TBL] [Abstract][Full Text] [Related]
7. Computational Methods to Study DNA:DNA:RNA Triplex Formation by lncRNAs.
Warwick T; Brandes RP; Leisegang MS
Noncoding RNA; 2023 Jan; 9(1):. PubMed ID: 36827543
[TBL] [Abstract][Full Text] [Related]
8. Natural antisense transcripts as drug targets.
Khorkova O; Stahl J; Joji A; Volmar CH; Zeier Z; Wahlestedt C
Front Mol Biosci; 2022; 9():978375. PubMed ID: 36250017
[TBL] [Abstract][Full Text] [Related]
9. LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of
Ge B; Zhang X; Zhou W; Mo Y; Su ZH; Xu G; Chen Q
Cell J; 2022 Jun; 24(6):294-301. PubMed ID: 35892231
[TBL] [Abstract][Full Text] [Related]
10. Strategies of LncRNA DLX6-AS1 on Study and Therapeutics.
Zhao Y; Li P
Front Genet; 2022; 13():871988. PubMed ID: 35719380
[TBL] [Abstract][Full Text] [Related]
11. DLX6-AS1: A Long Non-coding RNA With Oncogenic Features.
Ghafouri-Fard S; Najafi S; Hussen BM; Ganjo AR; Taheri M; Samadian M
Front Cell Dev Biol; 2022; 10():746443. PubMed ID: 35281110
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature.
Ding H; Jiang F; Deng L; Wang J; Wang P; Ji M; Li J; Shi W; Pei Y; Li J; Zhang Y; Zhang Z; Chen Y; Li B
Front Cell Dev Biol; 2021; 9():814456. PubMed ID: 35178403
[TBL] [Abstract][Full Text] [Related]
13. Research progress of DLX6-AS1 in human cancers.
Luo Y; Ge P; Wang M; Chen H; Liu J; Wei T; Jiang Y; Qu J; Chen H
Hum Cell; 2021 Nov; 34(6):1642-1652. PubMed ID: 34508305
[TBL] [Abstract][Full Text] [Related]
14. The regulatory role of antisense lncRNAs in cancer.
Liu B; Xiang W; Liu J; Tang J; Wang J; Liu B; Long Z; Wang L; Yin G; Liu J
Cancer Cell Int; 2021 Aug; 21(1):459. PubMed ID: 34461912
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs in chromatin folding and nuclear organization.
Razin SV; Gavrilov AA
Cell Mol Life Sci; 2021 Jul; 78(14):5489-5504. PubMed ID: 34117518
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region.
Zhao H; Xu Q
J Cell Mol Med; 2020 Nov; 24(21):12572-12584. PubMed ID: 32951317
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
18. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
